PharmiWeb.com - Global Pharma News & Resources

Company Directory - Clinical Research

Synexus, Acurian, and Optimal are now AES. AES owns the most fully identified patient data. And we own the world’s largest network of clinical research sites.
Why ÅKRN as Your Medical Device CRO? We are flexible, agile, and with solid medical device expertise. We offer optimized regulatory and clinical services tailored to our clients and MedTech partners.
ASLAN Pharmaceuticals is a clinical-stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations.
Aptus Clinical is a specialist UK-based Clinical Contract Research Organisation (CRO) with particular expertise in oncology, rare diseases and advanced, cell and gene therapies. We have decades of experience in delivering complex and innovative trials, transforming potential into value.
A clinical stage integrated biotech company located in Seongnam, South Korea, focused on developing novel therapeutics for neurodegenerative and infectious diseases using the ARIDD® (Advanced, Rapid and Integrated Drug Development) platform.
A privately-owned global CRO offering fully integrated end-to-end services to deliver US Premarket Tobacco Product Applications (PMTA), EU Medicinal Product Applications (MAA) and EU Tobacco Product Directive (TPD) notifications.
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization.
Our mission is to consistently deliver excellent quality and perfect-for-purpose chemistry solutions, from lead optimisation through product launch and life-cycle management, to enable our customers to create the best innovative therapeutics.
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 200 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise.